TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EQ

Equillium Inc

Healthcare · Biotechnology

1.90$ +1.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement EQ
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0%
0.7% 0.3% 0.3% 89.2%
100.0% 100.0% 100.0% -89.2%
238.3% 102.6% 91.1% 9,879.2%
109.4% 37.6% 29.0% 8,300.8%
493.9% 140.2% 120.1% 18,180.0%
-393.9% -40.2% -20.1% -18,180.0%
6.7% 1.4% 0.0%
-396.1% -35.3% -18.8% -17,229.2%
287.3% 1.6% 0.9%
-396.1% -37.0% -19.6% -17,229.2%
-388.7% -33.6% -18.4% -17,140.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?